Taysha Gene Therapies, Inc. - TSHA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | RA Capital Management, L.P. | 9.9% | 32,886,242 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Peter Kolchinsky | 9.9% | 32,886,242 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | Rajeev Shah | 9.9% | 32,886,242 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | RA Capital Healthcare Fund, L.P. | 9.9% | 32,886,242 | View |
| May 15, 2026 | SCHEDULE 13G/A | Vestal Point Capital, LP | 6.3% | 18,000,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Ryan Wilder | 6.3% | 18,000,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | RTW Investments, LP | 7.0% | 20,689,084 | View |
| May 15, 2026 | SCHEDULE 13G/A | Roderick Wong | 7.0% | 20,689,084 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.